Bharat Biotech International Limited (BBIL) has announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.
Ενημερωτική διαδικτυακή εκδήλωση για τον εμβολιασμό στη μαθητική κοινότητα flynews.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from flynews.gr Daily Mail and Mail on Sunday newspapers.
«Ενημερωτική διαδικτυακή εκδήλωση για τον εμβολιασμό στη μαθητική κοινότητα» taxydromos.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taxydromos.gr Daily Mail and Mail on Sunday newspapers.